Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neoplastic Cells, Circulating × cabazitaxel × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Castrate-resistant Metastatic Prostate Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

cabazitaxel 1 Watchful Waiting 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02621190 2016-08-17

CARVE

Erasmus Medical Center

Phase 2 Withdrawn

Neoplastic Cells, Circulating, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡